These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3201524)

  • 1. Physiological disposition of intravenously administered 14C-labeled diltiazem in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1988; 10(4):401-9. PubMed ID: 3201524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):551-7. PubMed ID: 2815230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):558-66. PubMed ID: 2815231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of diltiazem and its metabolites after repeated multiple-dose treatments in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):543-50. PubMed ID: 2815229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose.
    Boyd RA; Chin SK; Don-Pedro O; Verotta D; Sheiner LB; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Oct; 46(4):408-19. PubMed ID: 2791444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sustained intravenous diltiazem infusion in healthy persons.
    Ellenbogen KA; Roark SF; Smith MS; McCarthy EA; Bjornsson TD; Pritchett EL
    Am J Cardiol; 1986 Nov; 58(11):1055-60. PubMed ID: 3776858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
    Schwarzwald CC; Sams RA; Bonagura JD
    J Vet Pharmacol Ther; 2006 Jun; 29(3):165-71. PubMed ID: 16669860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
    Blight AR; Henney HR
    Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter.
    Dias VC; Weir SJ; Ellenbogen KA
    Circulation; 1992 Nov; 86(5):1421-8. PubMed ID: 1423955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects.
    Sigusch H; Henschel L; Kraul H; Merkel U; Hoffmann A
    Pharmazie; 1994 Sep; 49(9):675-9. PubMed ID: 7972311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic studies of diltiazem in elderly versus young hypertensive patients.
    Abernethy DR; Montamat SC
    Am J Cardiol; 1987 Dec; 60(17):116I-120I. PubMed ID: 3687802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects.
    Downing SJ; Edwards D; Hollingsworth M
    Br J Pharmacol; 1987 Aug; 91(4):735-45. PubMed ID: 3664075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of diltiazem in patients undergoing continuous ambulatory peritoneal dialysis.
    Grech-Bélanger O; Langlois S; LeBoeuf E
    J Clin Pharmacol; 1988 May; 28(5):477-80. PubMed ID: 3392246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of a slow-release formulation of diltiazem after the administration of a single and repeated doses to healthy volunteers.
    Lefebvre M; Lacasse Y; Spénard J; Geadah D; Moisan R; Gossard D; Landriault H; Du Souich P; Caillé G
    Biopharm Drug Dispos; 1994 Apr; 15(3):227-42. PubMed ID: 7880983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of diltiazem in patients with liver cirrhosis.
    Kurosawa S; Kurosawa N; Owada E; Soeda H; Ito K
    Int J Clin Pharmacol Res; 1990; 10(6):311-8. PubMed ID: 2099357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics and pharmacokinetics of clentiazem and diltiazem in closed-chest anesthetized dogs.
    Giasson S; Garceau D; Homsy W; Dumont L
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):685-92. PubMed ID: 8573551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem blood pharmacokinetics in the pregnant and non-pregnant rabbit: maternal and foetal tissue levels.
    Bregante MA; Aramayona JJ; Fraile LJ; Garcia MA; Solans C
    Xenobiotica; 2000 Aug; 30(8):831-41. PubMed ID: 11037114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and haemodynamic effect of deacetyl diltiazem (M1) in rabbits after a single intravenous administration.
    Yeung PK; Feng JD; Buckley SJ
    Biopharm Drug Dispos; 1998 Mar; 19(2):109-13. PubMed ID: 9533111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers.
    Ericsson H; Bredberg U; Eriksson U; Jolin-Mellgård A; Nordlander M; Regårdh CG
    Anesthesiology; 2000 Apr; 92(4):993-1001. PubMed ID: 10754618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and hypotensive effect of diltiazem in rabbits: comparison of diltiazem with its major metabolites.
    Yeung PK; Feng JD; Buckley SJ
    J Pharm Pharmacol; 1998 Nov; 50(11):1247-53. PubMed ID: 9877310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.